| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3334440 | Surgical Pathology Clinics | 2014 | 15 Pages |
Abstract
Poorly differentiated thyroid carcinoma (PDTC) has been recognized for the past 30 years as an entity showing intermediate differentiation and clinical behavior between well-differentiated thyroid carcinomas (ie, papillary thyroid carcinoma and follicular thyroid carcinoma) and anaplastic thyroid carcinoma; however, there has been considerable controversy around the definition of PDTC. In this review, the evolution in the definition of PDTC, current diagnostic criteria, differential diagnoses, potentially helpful immunohistochemical studies, and molecular alterations are discussed with the aim of highlighting where the diagnosis of PDTC currently stands.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Namrata Setia, Justine A. Barletta,